Biomarker Monitoring Framework for Safe Tirzepatide Use with Hypothyroidism Establishing baseline biomarkers before starting tirzepatideincluding TSH, free T4, free T3, TPO antibodies, and metabolic panelprovides a clinical anchor for evaluating treatment response
Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials
Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus under the brand name Mounjaro and for chronic weight management in adults with obesity or overweight with weight-related comorbidities under the brand name Zepbound
How These Weight Loss Medications Work What Is Semaglutide
Zepbound is intended to be used together with a reduced-calorie diet and increased physical activity
Pairing genetic insights with clinical labs and provider oversight enables a precision-wellness approach: you can start tirzepatide armed with knowledge about your metabolic vulnerabilities, allow your provider to tailor dosing and nutritional support accordingly, and monitor outcomes proactively rather than reactively managing side effects